clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2023-101-11-549-555clinmed-653Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESОсобенности диагностики и лечения впервые диагностированной фибрилляции предсердийFeatures of diagnosis and treatment of newly diagnosed atrial fibrillationЛепендинС. O.LependinS. O.

Лепендин Сергей Олегович  — врач — сердечно-сосудистый хирург отделения рентгенохирургических методов диагностики и лечения сложных нарушений ритма сердца ФКУ  «ЦВКГ им. П.В. Мандрыка» 

107014, Москва

 

Lependin Sergey O.

107014, Moscow

lependins@mail.ruПаценкоМ. Б.PatsenkoM. B.

Паценко Михаил Борисович — канд. мед. наук, доцент, начальник кафедры терапии неотложных состояний филиала ВМА им. С.М. Кирова в г. Москве Минобороны России, главный терапевт Минобороны России

107392, Москва

Patsenko Mikhail B.

107392, Moscow

СурыгинаС. Е.SuriginaS. E.

Сурыгина Светлана Евгеньевна — преподаватель кафедры терапии неотложных состояний филиала ВМА им. С.М. Кирова в г. Москве 

107392, Москва

Surigina Svetlana E.

107392, Moscow

МорозоваН. В.MorozovaN. V.

Морозова Наталья Владимировна — врач отделения функциональной диагностики ЦВКГ им. П.В. Мандрыка Минобороны России

107014, Москва

Morozova Natalia V.

107014, Moscow

СтекловВ. И.SteklovV. I.

Стеклов Владимир Иванович  — д-р мед. наук, доцент, заведующий отделением рентгенохирургических методов диагностики и лечения сложных нарушений ритма сердца ЦВКГ им. П.В. Мандрыка Минобороны России

107014, Москва

Steklov Vladimir I.

107014, Moscow

ФКУ «Центральный военный клинический госпиталь им. П.В. Мандрыка» Минобороны РоссииРоссияCentral Military Clinical Hospital named after P.V. Mandrykа of the Ministry of DefenseRussian FederationФГБВОУ ВО Филиал военно-медицинской академии им. С.М. Кирова в г. Москве, Минобороны РоссииРоссияBranch Military Medical Academy named after S.M. Kirov in Moscow of the Ministry of DefenseRussian Federation20231312202310111549555Copyright © Лепендин С.O., Паценко М.Б., Сурыгина С.Е., Морозова Н.В., Стеклов В.И., 20232023Лепендин С.O., Паценко М.Б., Сурыгина С.Е., Морозова Н.В., Стеклов В.И.Lependin S.O., Patsenko M.B., Surigina S.E., Morozova N.V., Steklov V.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/653

Ввиду широкого распространения в популяции и высокого риска осложнений фибрилляция предсердий является важной нозологией, к раннему выявлению и диагностике которой должны быть готовы врачи как поликлинического, так и госпитального звена. Отсутствие специфических симптомов и однозначных причин возникновения и множество ассоциированных клинических состояний означают, что знания о фибрилляции предсердий и особенно ее дебюте —  впервые диагностированной фибрилляции предсердий — особенно необходимы врачам-терапевтам. Данная статья представляет собой анализ литературы, посвященной впервые диагностированной фибрилляции предсердий, и уделяет внимание особенностям течения заболевания, его диагностике, выборе тактики и лечению. Статья знакомит читателя с информацией из современных общедоступных публикаций, посвященных данной теме, дает представление об основных этапах исторического развития медицины в этом направлении. На основе литературных источников вскрыты существующие на сегодня проблемы недооценки опасности заболевания, отсутствия единых подходов к тактике ведения пациента, ключевых определений и понятий

Due to the wide spread in the population and high risk of complications, atrial fibrillation is an important nosology, and  doctors of both outpatient and hospital departments should be prepared for its early detection and diagnosis. The absence of  specific symptoms and clear causes of onset, as well as the many associated clinical conditions, mean that knowledge of atrial  fibrillation, especially its debut — the first diagnosed atrial fibrillation — is particularly necessary for general practitioners.  This article analyzes literature on first diagnosed atrial fibrillation, focusing on the peculiarities of the disease’s course,  diagnosis, choice of tactics, and treatment. The article introduces readers to information from modern publicly available  publications on this topic, providing an overview of the key stages in the historical development of medicine in this area.  Based on literary sources, existing problems of underestimating the danger of the disease, lack of unified approaches to patient  management, and key definitions and concepts are revealed today.

впервые диагностированная фибрилляция предсердийтактика ведения пациентаосложнения поздней диагностикивосстановление синусового ритма в ранние срокиfi rst diagnosed atrial fi brillationpatient management tacticscomplications of late diagnosisrestoration of sinus rhythm in early stagesReferencesБокерия Л.А., Ревишвили А.Ш., Оганов Р.Г. и др. Клинические рекомендации по диагностике и лечению пациентов с фибрилляцией предсердий. Вестник аритмологии. 2010;59:53–57.Bokeria L.A., Revishvili A.Sh., Oganov R.G. et. al. Clinical guidelines on diagnostics and treatment of patients with atrial fi brillation. Journal of Arrhythmology. 2010;59(59):53–77. (In Russian).Go A.S., Hylek E.M., Phillips K.A. et. al. Prevalence of diagnosed atrial fi brillation in adults national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fi brillation (ATRIA) study. JAMA. 2001;285(18):2370–2375.Go A.S., Hylek E.M., Phillips K.A. et. al. Prevalence of diagnosed atrial fi brillation in adults national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fi brillation (ATRIA) study. JAMA. 2001;285(18):2370–2375.Cheung J.W., Keating R.J., Stein K.M. et al. Newly detected atrial fi brillation following dual chamber pacemaker implantation. Journal of Cardiovascular Electrophysiology. 2006;17(12):1323–1328. DOI: 10.1111/j.1540-8167.2006.00648.xCheung J.W., Keating R.J., Stein K.M. et al. Newly detected atrial fi brillation following dual chamber pacemaker implantation. Journal of Cardiovascular Electrophysiology. 2006;17(12):1323–1328. DOI: 10.1111/j.1540-8167.2006.00648.xKiliszek M., Ponikowski P., Opolski G. Cardioversion diff erences among fi rst detected episode, paroxysmal, and persistent atrial fi brillation patients in the RHYTHM AF registry in Poland. Cardiology Journal. 2015;22(4):453–458. DOI: 10.5603/CJ.a2015.0006Kiliszek M., Ponikowski P., Opolski G. Cardioversion diff erences among fi rst detected episode, paroxysmal, and persistent atrial fi brillation patients in the RHYTHM AF registry in Poland. Cardiology Journal. 2015;22(4):453–458. DOI: 10.5603/CJ.a2015.0006Bunch T.J., Day J.D., Olshansky B. et al. Newly detected atrial fi brillation in patients with an implantable cardioverter-defi brillator is a strong risk marker of increased mortality. Heart Rhythm. 2009;6(1):2–8. DOI: 10.1016/j.hrthm.2008.09.025Bunch T.J., Day J.D., Olshansky B. et al. Newly detected atrial fi brillation in patients with an implantable cardioverter-defi brillator is a strong risk marker of increased mortality. Heart Rhythm. 2009;6(1):2–8. DOI: 10.1016/j.hrthm.2008.09.025Бова А.А. Фибрилляция предсердий в практике терапевта. Военная медицина . 2018;1:6–10.Bova A.A. Atrial fi brillation in therapeutic practice. Voennaya medicina. 2018;1:6–10. (In Russian).Багрий А.Э., Приколота О.А., Котова К.А. и др. Стратегии контроля ритма и контроля частоты сокращений желудочков при впервые выявленной фибрилляции предсердий. Крымский терапевтический журнал. 2021;2:25–33.Bаgry А.E., Prikolota O.A., Kotova K.A., Vashakidze N.O., Derevyanko N.Ya., Gritskevich O.S., Bаgry O.N. Rate and rhythm control treatment strategies of new lydiagnosed atrial fi brillation. Crimean journal of internal diseases. 2021;2:25–33. (In Russian).Nieuwlaat R., Capucci A., Camm A.J. et al. Atrial fi brillation management: a prospective survey in ESC member countries the euro heart survey on atrial fi brillation. Eur. Heart J. 2005;26:2422– 2434. DOI:10.1093/eurheartj/ehi505Nieuwlaat R., Capucci A., Camm A.J. et al. Atrial fi brillation management: a prospective survey in ESC member countries the euro heart survey on atrial fi brillation. Eur. Heart J. 2005;26:2422– 2434. DOI:10.1093/eurheartj/ehi505Hammond-Haley M., Providência R., Lambiase P.D. Temporal pattern/episode duration-based classifi cation of atrial fi brillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management? Europace. 2018;20(FI3):f288–f298. DOI: 10.1093/europace/eux178Hammond-Haley M., Providência R., Lambiase P.D. Temporal pattern/episode duration-based classifi cation of atrial fi brillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management? Europace. 2018;20(FI3):f288–f298. DOI: 10.1093/europace/eux178McIntyre W.F., Um K.J., Cheung Ch.C. et al. Atrial fi brillation detected initially during acute medical illness: A systematic review. European Heart Journal: Acute Cardiovascular Care. 2019;8(2):130–141. DOI: 10.1177/2048872618799748McIntyre W.F., Um K.J., Cheung Ch.C. et al. Atrial fi brillation detected initially during acute medical illness: A systematic review. European Heart Journal: Acute Cardiovascular Care. 2019;8(2):130–141. DOI: 10.1177/2048872618799748Reiff el J.A., Verma A., Kowey P.R. Incidence of previously undiagnosed atrial fi brillation using insertable cardiac monitors in a high-risk population the REVEAL AF study. JAMA. Cardiology Published online. 2017;2(10):1120 –1127. DOI:10.1001/jamacardio.2017.3180Reiff el J.A., Verma A., Kowey P.R. Incidence of previously undiagnosed atrial fi brillation using insertable cardiac monitors in a high-risk population the REVEAL AF study. JAMA. Cardiology Published online. 2017;2(10):1120 –1127. DOI:10.1001/jamacardio.2017.3180Garnvik L.E., Malmo V., Janszky I. Physical activity modifi es the risk of atrial fi brillation in obese individuals: The HUNT3 study. European Journal of PreventiveCardiology. 2018;25(15):1646– 1652. DOI: 10.1177/2047487318784365Garnvik L.E., Malmo V., Janszky I. Physical activity modifi es the risk of atrial fi brillation in obese individuals: The HUNT3 study. European Journal of PreventiveCardiology. 2018;25(15):1646– 1652. DOI: 10.1177/2047487318784365Romanov A., Martinek M., Purerfellner H. et al. Incidence of atrial fi brillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. Europace. 2018;20(2):263–270. DOI: 10.1093/europace/euw344Romanov A., Martinek M., Purerfellner H. et al. Incidence of atrial fi brillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. Europace. 2018;20(2):263–270. DOI: 10.1093/europace/euw344Mazza A., GraziaBendini M., De Cristofaro R. et al. Pacemakerdetected severe sleep apnea predicts new-onset atrial fi brillation. Europace. 2017;19(12):1937–1943. DOI: 10.1093/europace/euw371Mazza A., GraziaBendini M., De Cristofaro R. et al. Pacemakerdetected severe sleep apnea predicts new-onset atrial fi brillation. Europace. 2017;19(12):1937–1943. DOI: 10.1093/europace/euw371Freedman B. et al. Screening for atrial fi brillation. A report of the af-screen international collaboration. Circulation. 2017;135:1851– 1867. DOI: 10.1161/CIRCULATION AHA.116.026693Freedman B. et al. Screening for atrial fi brillation. A report of the af-screen international collaboration. Circulation. 2017;135:1851– 1867. DOI: 10.1161/CIRCULATION AHA.116.026693Kikillus N., Hammer G., Wieland S. et al. Algorithm for identifying patients with paroxysmal atrial fi brillation without appearance on the ECG. Proceedings of the 29th Annual International Conference of the IEEE EMBS. 2007.2007;2007:275–278. DOI: 10.1109/IEMBS.2007.4352277Kikillus N., Hammer G., Wieland S. et al. Algorithm for identifying patients with paroxysmal atrial fi brillation without appearance on the ECG. Proceedings of the 29th Annual International Conference of the IEEE EMBS. 2007.2007;2007:275–278. DOI: 10.1109/IEMBS.2007.4352277Bassand J.-P., Accetta G., Camm A.J. et al. Two-year outcomes of patients with newly diagnosed atrial fi brillation: results from GARFIELD-AF. European Heart Journal. 2016;37(38):2882–2889. DOI: 10.1093/eurheartj/ehw233Bassand J.-P., Accetta G., Camm A.J. et al. Two-year outcomes of patients with newly diagnosed atrial fi brillation: results from GARFIELD-AF. European Heart Journal. 2016;37(38):2882–2889. DOI: 10.1093/eurheartj/ehw233Bulanova N.A. Atrial fi brillation registered for the fi rst time: characteristics of clinical course, treatment, prognosis. Article in Kardiologiia. 2013;53(2):25–29.Bulanova N.A. Atrial fi brillation registered for the fi rst time: characteristics of clinical course, treatment, prognosis. Article in Kardiologiia. 2013;53(2):25–29.Levy S., Maarek M., Coumel Ph. et al. Characterization of diff erent subsets of atrial fi brillation in general practice in France the ALFA study. Circulation. 1999;99:3028–3035. DOI: 10.1161/01.CIR.99.23.3028Levy S., Maarek M., Coumel Ph. et al. Characterization of diff erent subsets of atrial fi brillation in general practice in France the ALFA study. Circulation. 1999;99:3028–3035. DOI: 10.1161/01.CIR.99.23.3028Шляхто Е.В., Ежов А.В., Зенин С.А. и др. Клинический портрет пациента с фибрилляцией предсердий в Российской Федерации. Данные глобального регистра Gloria AF. Российский кардиологический журнал. 2017;9:149.Shlyakhto E.V., Villevalde S.V., Ezhov A.V., Zenin S.A. et al. Clinical performance of the atrial fi brillation in the Russian. fi ndings from the GLORIA-AF. Russian Journal of Cardiology. 2017;9:149. (In Russian.).Boriani G., Glotzer T.V., Ziegler P.D. et al. Detection of new atrial fi brillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fi brillation burden. Heart Rhythm. 2017;15(3):376–383. DOI: an10.1016/j.hrthm.2017.11.007Boriani G., Glotzer T.V., Ziegler P.D. et al. Detection of new atrial fi brillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fi brillation burden. Heart Rhythm. 2017;15(3):376–383. DOI: an10.1016/j.hrthm.2017.11.007Сноу В., Уэллс К., Лефевр М. и др. Рекомендации американской академии семейных врачей и американского колледжа терапевтов по тактике ведения пациентов с впервые выявленной фибрилляцией предсердий. Анналы аритмологии. 2005;2:5–16.Snow V., Welss K.B., LeFevre M. et al. Management of newly detected atrial fi brillation:a clinical practice guideline from the American academy of family physicians and the american college of physicians. Annaly aritmologii. 2005;2:5–16. (In Russian)].Pluymaekers H.A., Dudink M. P., Weijs B. et al. Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fi brillation. Neth. Heart J. 2021;29:255–261. DOI: 10.1007/s12471-020-01528-5Pluymaekers H.A., Dudink M. P., Weijs B. et al. Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fi brillation. Neth. Heart J. 2021;29:255–261. DOI: 10.1007/s12471-020-01528-5Cosio F.G., Aliot E., Botto G.L. Delayed rhythm control of atrial fi brillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the fi rst detected episode. Europace. 2008;10:21–27. DOI:10.1093/europace/eum276Cosio F.G., Aliot E., Botto G.L. Delayed rhythm control of atrial fi brillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the fi rst detected episode. Europace. 2008;10:21–27. DOI:10.1093/europace/eum276Kirchhof P., Camm A.J., Goette A. et al. Early rhythm-control therapy in patients with atrial fi brillation. N. Engl. J. Мed. 2020;383(14):1305–1316. DOI: 10.1056/NEJMoa2019422Kirchhof P., Camm A.J., Goette A. et al. Early rhythm-control therapy in patients with atrial fi brillation. N. Engl. J. Мed. 2020;383(14):1305–1316. DOI: 10.1056/NEJMoa2019422Стеклов В.И., Паценко М.Б., Демьяненко А.В. и др. Критерии диагностики и лечение тахииндуцированной кардиомиопатии: клиническое наблюдение. Вестник аритмологии.2022;29(4):53–60. DOI: 10.35336/VA-2022-4-08Steklov V.I., Pashchenko M.B., Demyanenko A.V. et al. Diagnostic criteria and treatment of tachyinduced cardiomyopathy: clinical observation. Bulletin of Arrhythmology. 2022;29(4):53–60. (In Russian). DOI: 10.35336/VA-2022-4-08Pope M. K., Hall T.S., Schirripa V. et al. Cardioversion in patients with newly diagnosed non-valvular atrial fi brillation: observational study using prospectively collected registry data. BMJ. 2021;375:e066450. DOI: 10.1136/bmj-2021-066450Pope M. K., Hall T.S., Schirripa V. et al. Cardioversion in patients with newly diagnosed non-valvular atrial fi brillation: observational study using prospectively collected registry data. BMJ. 2021;375:e066450. DOI: 10.1136/bmj-2021-066450Hellman T., Kiviniemi T., Vasankari T.et al. Prediction of ineff ective elective cardioversion of atrial fi brillation: a retrospective multicenter patient cohort study. BMC Cardiovascular Disorders. 2017;17:33. DOI:10.1186/s12872-017-0470-0Hellman T., Kiviniemi T., Vasankari T.et al. Prediction of ineff ective elective cardioversion of atrial fi brillation: a retrospective multicenter patient cohort study. BMC Cardiovascular Disorders. 2017;17:33. DOI:10.1186/s12872-017-0470-0McIntyre W.F., Lengyel A.P., Healeyet J.S. et al. Design and rationale of the atrial fi brillation occurring transiently with stress (AFOTS) incidence study. Journal of Electrocardiology. 2019;57:95–99. DOI: 10.1016/j.jelectrocard.2019.09.014McIntyre W.F., Lengyel A.P., Healeyet J.S. et al. Design and rationale of the atrial fi brillation occurring transiently with stress (AFOTS) incidence study. Journal of Electrocardiology. 2019;57:95–99. DOI: 10.1016/j.jelectrocard.2019.09.014Philippsen T.J., Christensen L.S., Hansen M.G. et al. Detection of subclinical atrial fi brillation in high-risk patients using insertable cardiac monitor. JACC: Clinical electrophysiology. 2017;3(13):1557– 1564. DOI: 10.1016/j.jacep.2017.06.020Philippsen T.J., Christensen L.S., Hansen M.G. et al. Detection of subclinical atrial fi brillation in high-risk patients using insertable cardiac monitor. JACC: Clinical electrophysiology. 2017;3(13):1557– 1564. DOI: 10.1016/j.jacep.2017.06.020

The authors declare that there are no conflicts of interest present.